See the DrugPatentWatch profile for Contrave
Contrave is a weight-loss medication that combines two active ingredients: naltrexone hydrochloride and bupropion hydrochloride [1]. Naltrexone is an opioid antagonist, and bupropion is an antidepressant [1]. The medication is approved for chronic weight management in adults with a body mass index (BMI) of 30 kg/m² or greater, or in adults with a BMI of 27 kg/m² or greater who have at least one weight-related comorbidity, such as hypertension, type 2 diabetes, or dyslipidemia [1]. It is intended for use in conjunction with a reduced-calorie diet and increased physical activity [1].
How does Contrave work for weight loss?
The exact mechanism by which Contrave promotes weight loss is not fully understood, but it is believed to involve the interplay of naltrexone and bupropion in the brain. Bupropion affects parts of the brain involved in appetite regulation and reward, while naltrexone blocks the receptors that can lead to cravings and overeating, particularly those related to the body's response to food [1]. This combination is thought to target the brain's appetite control system [1].
What are the potential side effects of Contrave?
Common side effects associated with Contrave include nausea, constipation, diarrhea, headache, vomiting, dizziness, dry mouth, insomnia, and fatigue [1]. Serious side effects can occur, such as increased blood pressure and heart rate, suicidal thoughts or behavior, and the risk of seizures [1]. Individuals with a history of seizure disorders, eating disorders, or those taking certain other medications may not be suitable candidates for Contrave [1].
When does the patent for Contrave expire?
The patent landscape for Contrave involves multiple patents covering the drug itself, its use, and manufacturing processes. Information on specific patent expiry dates can be complex and may be subject to legal challenges or extensions. DrugPatentWatch.com tracks these patents and their status, which can influence the availability of generic versions [2].
Can generic versions of Contrave become available?
The availability of generic versions of Contrave is contingent upon the expiration of relevant patents and any regulatory approvals required for generic manufacturing [2]. Patent expiry is a critical factor for generic drug market entry, as it opens the door for competitors to produce and market their own versions of the medication, potentially at a lower cost [2].
How does Contrave compare to other weight-loss medications?
Contrave competes in a market with several other prescription weight-loss drugs, each with different active ingredients and mechanisms of action. These include medications like semaglutide (Wegovy), liraglutide (Saxenda), phentermine/topiramate (Qsymia), and orlistat (Xenical, Alli) [3]. Patient response and side effect profiles can vary significantly between these medications, making the choice of treatment individualized [3].
What is the cost of Contrave?
The cost of Contrave can vary depending on insurance coverage, pharmacy, and location. Without insurance, it can be expensive, with prices often ranging from several hundred dollars per month [4]. Patient assistance programs may be available to help reduce the cost for eligible individuals [4].
What clinical data supports Contrave's effectiveness?
Clinical trials have demonstrated that Contrave, when used with a reduced-calorie diet and increased physical activity, leads to statistically significant weight loss compared to placebo [1]. Studies have reported average weight loss percentages over a year of treatment, showing a meaningful reduction in body weight for many patients [1].
What are the risks for patients considering Contrave?
Patients considering Contrave should be aware of the potential for serious side effects, including cardiovascular risks and psychiatric effects. A thorough medical evaluation is necessary to determine if the benefits of Contrave outweigh the risks for an individual patient, considering their medical history and other medications [1].
---
1. https://www.drugpatentwatch.com/drugs/contrave
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/drugs/semaglutide
4. https://www.drugpatentwatch.com/drugs/liraglutide